Skip to main content
main-content

Clinical trial summary slides

ORIGIN trial in patients with type 2 diabetes

This downloadable slide set summarizes the design and results of the ORIGIN study, which investigated the effect of titrated basal insulin glargine versus standard care and n-3 fatty acids versus placebo on cardiovascular (CV) outcomes in patients with (or at risk for) type 2 diabetes and other CV risk factors.

View and download slides

ADDITION-Europe trial in patients with type 2 diabetes

This downloadable slide set summarizes the design and results of the ADDITION-Europe study, which investigated whether early intensive multifactorial treatment improves cardiovascular outcomes when started after detection of type 2 diabetes by screening and before clinical diagnosis.

View and download slides

SUSTAIN-6 trial in patients with type 2 diabetes

This downloadable slide set summarizes the design and results of the SUSTAIN-6 study, which investigated the cardiovascular safety of the glucagon-like peptide-1 receptor agonist semaglutide in patients with type 2 diabetes.

View and download slides

TECOS trial in patients with type 2 diabetes

This downloadable slide set summarizes the design and results of TECOS, a cardiovascular outcomes study of the dipeptidyl peptidase-4 inhibitor sitagliptin in patients with type 2 diabetes.

View and download slides

SAVOR-TIMI 53 trial in patients with type 2 diabetes

This downloadable slide set summarizes the design and results of SAVOR-TIMI 53, a cardiovascular outcomes study of the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes.

View and download slides

LEADER trial in patients with type 2 diabetes

This downloadable slide set summarizes the design and results of the LEADER study, a cardiovascular safety trial of the glucagon-like peptide-1 receptor agonist liraglutide in patients with type 2 diabetes.

View and download slides

EXAMINE trial in patients with type 2 diabetes

This downloadable slide set summarizes the design and results of the EXAMINE study, which investigated the cardiovascular safety of the dipeptidyl peptidase-4 inhibitor alogliptin in subjects with type 2 diabetes and acute coronary syndromes.

View and download slides

EMPA-REG OUTCOME trial in patients with type 2 diabetes

This downloadable slide set summarizes the design and results of the EMPA-REG OUTCOME study, a cardiovascular safety study of the sodium-glucose cotransporter 2 inhibitor empagliflozin in patients with type 2 diabetes.

View and download slides

ELIXA trial in patients with type 2 diabetes

This downloadable slide set summarizes the design and results of ELIXA, a cardiovascular outcomes study of the glucagon-like peptide-1 receptor agonist lixisenatide in patients with type 2 diabetes.

View and download slides
image credits